Image

Indicators Affecting PVT Recanalization

Indicators Affecting PVT Recanalization

Recruiting
18-80 years
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.

Eligibility

Inclusion Criteria:

  • diagnosed as cirrhosis and confirmed gastroesophageal varices by endoscopy;
    • all patients were diagnosed as PVT by CTA at admission.

Exclusion Criteria:

  • patients with hepatocellular carcinoma;
    • patients with extrahepatic malignancies;
      • history of liver transplantation or TIPS;
        • lack of information regarding anticoagulation therapy；
          • those with cavernous transformation of the portal vein(CTPV) .

Study details
    Portal Vein Thrombosis
    Cirrhosis
    Portal Hypertension Related to Cirrhosis
    Portal Hypertension
    Noncirrhotic

NCT07473375

Shanghai Zhongshan Hospital

13 May 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.